Skip to main content

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 5))

  • 47 Accesses

Abstract

It is appropriate to start this article by looking back briefly at the recent development of our knowledge of hepatitis viruses, of hepatitis as a disease, and of its natural history because this process is the background to the specific immune prophylaxis of hepatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Blumberg, B.S., Gerstley, B.J.S., Hungerford, D.A., London, W.T., Sutnick, A.I.: A serum antigen (Australia antigen) in Down’s Syndrome, leukemia and hepatitis. Ann. Int. Med. 66: 924, 1967.

    Article  CAS  PubMed  Google Scholar 

  2. Crosnier, J., Jungers, P., Couroucé, A.M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., Guesry, P.: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I. Medical staff. Lancet 1: 455, 1981.

    Article  CAS  PubMed  Google Scholar 

  3. Crosnier, J., Jungers, P., Couroucé, A.M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., Guesry, P.: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II. Haemodialysis patients. Lancet 2: 797, 1981.

    Article  Google Scholar 

  4. Deinhardt, F.: Immune prophylaxis of viral hepatitis. Behring Institute Mitteilungen 69: 36, 1981.

    Google Scholar 

  5. Deinhardt, F.: Serum markers of hepatitis in natural disease and after vaccination. In: Progress in Liver Disease, volume VII. Editors: H. Popper and F. Schaffner. Grune and Stratton, New York, in press.

    Google Scholar 

  6. Deinhardt, F., Zachoval, R., Schmidt, M., Frösner, H., Frösner, G. G.: Active and passive-active immunization against hepatitis virus infection. In: Hepatitis B Vaccine. Editors: P. Maupas and P. Guesl Elsevier, Amsterdam, 1981, p. 167.

    Google Scholar 

  7. Dienstag, J.L.: The pathobiology of hepatitis A virus. International Rev. Exp. Pathol. 20: 1, 1979.

    CAS  Google Scholar 

  8. Dreesman, G.R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J.T., Six, H.R., Peterson, D.L., Hollinger, F.B., Meinick, J.L.: Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature 295: 158, 1982.

    Article  CAS  PubMed  Google Scholar 

  9. Gauss-Müller, V., Frösner, G.G., Deinhardt, F.: Propagation of hepatitis A virus in human fibroblasts. J. Virol. Meth. 7: 233, 1981.

    Article  Google Scholar 

  10. Gerety, R.J.(editor): Non-A, Non-B Hepatitis. Academic Press, New York, 1981, p. 1–301.

    Google Scholar 

  11. Hilleman, M.R., Buynak, E.B., McAleer, J., MacLean, A.A., Provost, P.J., Tytell, A.A.: Newer developments with human hepatitis vaccines. In: Perspectives in Virology IX. Editor: M. Pollard. Allan R. Liss, New York, 1981, p. 219.

    Google Scholar 

  12. Hollinger, F.B., Adam, E., Heiberg, D., Melnick, J.L.: Response to hepatitis B vaccine in a young adult population. In: Viral Hepatitis: 1981 International Symposium. Editors: W. Szmuness, J.W. Maynard and H.J. Alter. The Franklin Institute Press, Philadelphia, PA, 1982, p. 451.

    Google Scholar 

  13. Krugman, S., Giles, J.P., Hammond, J.: Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. J. Infect. Dis. 122: 432, 1970.

    Article  CAS  PubMed  Google Scholar 

  14. Krugman, S., Giles, J.P., Hammond, J.: Viral hepatitis, type B (MS-2 strain): studies on active immunization. J. Amer. Med. Ass. 217: 41, 1971.

    Article  CAS  Google Scholar 

  15. Lerner, R.A., Green, N., Alexander, H., Liu, F.-T., Sutcliffe, J. G., Shinnick, T.M.: Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proceedings of the National Academy of Sciences, USA 78: 3403, 1981.

    Article  CAS  Google Scholar 

  16. Maupas, P., Barin, F., Chiron, J.P., Coursaget, P., Goudeau, A., Perrin, F., Denis, F., Diop, Mar. I.: Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet 1: 289, 1981.

    Article  CAS  PubMed  Google Scholar 

  17. Maupas, P., Guesry, P. (editors): Hepatitis B Vaccine (INSERM symposium 18). Elsevier, Amsterdam, 1981, p. 1–318.

    Google Scholar 

  18. McAuliffe, V.J., Purcell, R.H., Gerin, J.L.: Type B hepatitis: a review of current prospects for a safe and effective vaccine. Rev. Infect. Dis. 2: 470, 1980.

    Article  CAS  PubMed  Google Scholar 

  19. Prince, A.M., Fuji, H., Gershon, R.K.: Immunohistochemical studies on the etiology of anicteric hepatitis in Korea. Amer. J. Hyg. 79: 365, 1964.

    CAS  PubMed  Google Scholar 

  20. Siegl, G., Frösner, G.G., Gauss-Müller, V., Tratschin, J.D., Deinhardt, F.: The physicochemical properties of infectious hepatitis A virions. J. Gen. Virol. 57: 331, 1981.

    Article  CAS  PubMed  Google Scholar 

  21. Stevens, C.E., Szmuness, W., Goodman, A.I., Weseley, S.A., Fotino, M.: Hepatitis B vaccine: immune responses in haemodialysis patients. Lancet 2: 1211, 1980.

    Article  CAS  PubMed  Google Scholar 

  22. Szmuness, W., Oleszko, W.R., Stevens, C.E., Goodman, A.: Passive-active immunization against hepatitis B: immunogenicity studies in adult Americans. Lancet 1: 575, 1981.

    Article  CAS  PubMed  Google Scholar 

  23. Szmuness, W., Stevens, C.E., Zang, E.A., Harley, E.J., Kellner, A.: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1: 377, 1981.

    Article  CAS  PubMed  Google Scholar 

  24. Tiollais, P., Charnay, P., Vyas, G.N.: Biology of hepatitis B virus. Science 213: 406, 1981.

    Article  CAS  PubMed  Google Scholar 

  25. Von der Helm, K., Winnacker, E.L., Deinhardt, F., Frösner, G.G., Gauss-Müller, V., Bayerl, B., Scheid, R., Siegl, G.: Cloning of hepatitis A virus genome. J. Virol. Meth. 3: 37, 1981.

    Article  Google Scholar 

  26. Zachoval, R., Frösner, G.G., Deinhardt, F.: Impfung gegen Hepatitis B. Munch. Med. Wschr. 40: 1506, 1981.

    Google Scholar 

  27. Zuckerman, A.J.: Hepatitis B: its prevention by vaccine. J. Infect. Dis. 143: 301, 1981.

    Article  CAS  PubMed  Google Scholar 

  28. Zuckerman, A.J., Howard, C.: Hepatitis viruses in man. Academic Press, New York, 1979, p. 1–269.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Deinhardt, F. (1982). Hepatitis B Virus Vaccine. In: Smit Sibinga, C.T., Das, P.C., van Loghem, J.J. (eds) Bloodtransfusion and Problems of Bleeding. Developments in Hematology and Immunology, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7692-4_29

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7692-4_29

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7694-8

  • Online ISBN: 978-94-009-7692-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics